牙周炎患者磨牙拔牙位点微创嵴顶瓣牙槽嵴保存的随机对照试验
这项随机对照试验纳入56例III/IV期牙周炎患者的70个磨牙拔牙位点,比较微创嵴顶瓣牙槽嵴保存(MCF-ARP)与自然愈合(NH)的软硬组织变化。术后6个月,MCF-ARP组颊侧骨高度吸收更少、中央骨高度和嵴宽增加更多,颊侧软组织轮廓塌陷更小,且需要分期植骨的位点更少。
要点
- MCF-ARP可减少牙周受损磨牙拔牙位点的骨吸收并维持颊侧软组织轮廓。
- MCF-ARP组需分期植骨的位点比例为0%,显著低于NH组的26.7%。
- MCF-ARP组可行简单种植程序的位点比例更高(71.9% vs 56.6%)。
核心结论
- 与自然愈合相比,MCF-ARP减少了牙周受损磨牙拔牙位点的骨吸收并维持了颊侧软组织轮廓。
- MCF-ARP降低了种植治疗中复杂骨增量程序的需求。
研究设计与样本
- 随机对照试验,56例III/IV期牙周炎患者的70个磨牙拔牙位点按位点随机分组。
- 试验组35个位点(来自31例患者),对照组35个位点(来自29例患者)。
- 硬组织指标用拔牙前和术后6个月的锥形束CT测量,软组织轮廓用术前、术后即刻及术后2周、1、3、6个月的口内扫描评估。
主要发现
- 术后6个月,MCF-ARP组颊侧骨高度吸收更少(p = .032),中央骨高度增加更多(p = .001),嵴宽增加更多(p = .009)。
- MCF-ARP组颊侧软组织轮廓的平均、垂直和水平塌陷分别比NH组少0.95 mm(p = .010)、0.61 mm(p = .019)和0.56 mm(p = .013)。
- MCF-ARP组需分期植骨的位点显著少于NH组(0% vs. 26.7%,p = .007),可行简单种植程序的位点更多(71.9% vs. 56.6%)。
临床怎么用
- 对III/IV期牙周炎患者的磨牙拔牙位点,可考虑采用MCF-ARP以减少骨吸收并简化后续种植程序。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: This study aimed to assess hard and soft tissue contour changes following micro crestal flap-alveolar ridge preservation (MCF-ARP) and natural healing (NH) in periodontally compromised molar extraction sites and to analyse the feasibility and need for bone augmentation during implant therapy. MATERIALS AND METHODS: Fifty-six patients with 70 sites were randomized into two groups at the site level (35 sites from 31 patients in the test group and 35 sites from 29 patients in the control group). Among whom, four patients contributed one tooth to the control group and one tooth to the test group. Hard tissue indicators were measured using cone beam computed tomography performed before tooth extraction and 6 months after surgery. Soft tissue contour changes were assessed using intraoral scanning performed before and immediately after surgery and also 2 weeks and 1, 3 and 6 months after surgery. RESULTS: Six months after surgery, the MCF-ARP group showed less resorption in buccal bone height (p = .032) and greater augmentation in central bone height (p = .001) and ridge width (p = .009). The mean, vertical and horizontal collapse of buccal soft tissue contour in the MCF-ARP group were 0.95 mm (p = .010), 0.61 mm (p = .019) and 0.56 mm (p = .013) less than that in the NH group, respectively. There were significantly (p = .007) fewer sites in the MCF-ARP group than in the NH group (0% vs. 26.7%) for staged bone augmentation and more sites that could be treated with simple implant procedure in the MCF-ARP group than in the NH group (71.9% vs. 56.6%). CONCLUSIONS: Compared with NH, MCF-ARP reduced bone resorption in periodontally compromised molar extraction sites and maintained the buccal soft tissue contour. MCF-ARP reduces the need for complex bone augmentation procedures in implant therapy. TRIAL REGISTRATION: Chinese Clinical Trial Register (ChiCTR) ChiCTR2200056335. Registered on 4 February 2022, Version 1.0.
引用
- Zhang H, Xu T, Wei Y, et al. Assessment of soft and hard tissue changes following micro crestal flap-Alveolar ridge preservation and augmentation at molar extraction sites in patients with stage III/IV periodontitis: A randomized controlled trial. J Clin Periodontol. 2024. PMID: 39043452. doi:10.1111/jcpe.14045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。